...
首页> 外文期刊>BMC Complementary and Alternative Medicine >Extraction and purification of total flavonoids from pine needles of Cedrus deodara contribute to anti-tumor in vitro
【24h】

Extraction and purification of total flavonoids from pine needles of Cedrus deodara contribute to anti-tumor in vitro

机译:雪松松针中总黄酮的提取和纯化有助于体外抗肿瘤

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Cedrus deodara is one of the traditional Chinese medicinal herbs that exhibits a line of biological activities. The current study extracted the total flavonoids from the pine needles of Cedrus deodara (TFPNCD), and investigated its anti-cancer effects in tumor cell lines. Methods The total flavonoids was extracted from pine needles of Cedrus deodara by ethanol hot refluxing and purified by HPD722 macroporous resin. The contents of total flavonoids and the active ingredients of TFPNCD were analyzed through UV and HPLC. MTT assay was used to investigate its inhibitory effect on tumor cell lines. The flow cytometry was employed to determine the apoptosis and cell cycle distribution after treated TFPNCD on HepG2 cells. Results The TFPNCD, in which the contents of total flavonoid reached up to 54.28 %, and the major ingredients of myricetin, quercetin, kaempferol and isorhamnetin in TFPNCD were 1.89, 2.01, 2.94 and 1.22 mg/g, respectively. The MTT assays demonstrated that TFPNCD inhibited the growth of HepG2 cells in a dose-dependent manner, with the IC50?values of 114.12 μg/mL. By comparison, TFPNCD inhibited the proliferation to a less extent in human cervical carcinoma HeLa, gastric cancer MKN28 cells, glioma SHG-44 cells and lung carcinoma A549 than HepG2 cells. We found that even at the lower doses, the total flavonoids effectively inhibited the proliferation of HepG2 cells. Comparison of IC50 values implicated that HepG2 cells might be more sensitive to the treatment with total flavonoids. TFPNCD was able to increase the population of HepG2 cells in G0 /G1 phase. Meanwhile, TFPNCD treatment increased the percentage of apoptotic HepG2 cells. Conclusion These data suggested that TFPNCD might have therapeutic potential in cancer through the regulation of cell cycle and apoptosis.
机译:背景雪松(Cedrus deodara)是显示一系列生物活性的传统中草药之一。目前的研究从雪松(Cedrus deodara)的松针中提取了总黄酮(TFPNCD),并研究了其在肿瘤细胞系中的抗癌作用。方法采用乙醇热回流法从雪松松针中提取总黄酮,并用HPD722大孔树脂纯化。通过UV和HPLC分析总黄酮和TFPNCD活性成分的含量。使用MTT法研究其对肿瘤细胞系的抑制作用。流式细胞仪用于确定TFPNCD在HepG2细胞上后的凋亡和细胞周期分布。结果TFPNCD中总黄酮含量高达54.28%,杨梅,槲皮素,山奈酚和异鼠李素的主要成分分别为1.89、2.01、2.94和1.22 mg / g。 MTT分析表明,TFPNCD以剂量依赖性方式抑制HepG2细胞的生长,IC <50> 50 值为114.12μg/ mL。相比之下,TFPNCD在人宫颈癌HeLa,胃癌MKN28细胞,神经胶质瘤SHG-44细胞和肺癌A549中的抑制作用要小于HepG2细胞。我们发现,即使在较低剂量下,总类黄酮也能有效抑制HepG2细胞的增殖。 IC 50 值的比较表明,HepG2细胞对总类黄酮的治疗可能更敏感。 TFPNCD能够增加G0 / G1期的HepG2细胞数量。同时,TFPNCD处理增加了凋亡的HepG2细胞的百分比。结论这些数据表明,TFPNCD通过调节细胞周期和凋亡可能具有治疗癌症的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号